Ventas price target raised to $79 from $78 at Wedbush

Wedbush raised the firm’s price target on Ventas to $79 from $78 and keeps an Outperform rating on the shares. While Ventas (VTR) and Welltower (WELL) own an otherwise diversified collection of health care property types, senior housing operating is by far the key to stock performance in both cases. Earnings for Q1 did not disappoint, Wedbush adds.